AR027247A1 - Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas. - Google Patents

Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas.

Info

Publication number
AR027247A1
AR027247A1 ARP010100232A ARP010100232A AR027247A1 AR 027247 A1 AR027247 A1 AR 027247A1 AR P010100232 A ARP010100232 A AR P010100232A AR P010100232 A ARP010100232 A AR P010100232A AR 027247 A1 AR027247 A1 AR 027247A1
Authority
AR
Argentina
Prior art keywords
pets
treatment
intended
food
helicobacter species
Prior art date
Application number
ARP010100232A
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170924&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR027247(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of AR027247A1 publication Critical patent/AR027247A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/805—Pet food for dog, cat, bird, or fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Uso de por lo menos una cepa de bacterias lácticas y/o sus metabolitos o un medio fermentado por a lo menos una bacteria láctica que ha sido aislada yselleccionada por suc apacidad para desplegar una poderosa actividad bactericida anti-helicobacter i n vitro, apra la preparacion de una composicion destinada ala profilaxis o al tratamiento de trstornos relacionados con la infeccion, producida por los GHLO en las mascotas y las composiciones de alimentos paramascotas que contienen la misma.
ARP010100232A 2000-01-18 2001-01-18 Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas. AR027247A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00200179 2000-01-18

Publications (1)

Publication Number Publication Date
AR027247A1 true AR027247A1 (es) 2003-03-19

Family

ID=8170924

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100232A AR027247A1 (es) 2000-01-18 2001-01-18 Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas.

Country Status (18)

Country Link
US (1) US7910144B2 (es)
EP (1) EP1251747B1 (es)
JP (2) JP5148796B2 (es)
AR (1) AR027247A1 (es)
AT (1) ATE542434T1 (es)
AU (1) AU784898B2 (es)
BR (1) BR0016973A (es)
CA (1) CA2396958C (es)
CO (1) CO5280056A1 (es)
ES (1) ES2378811T3 (es)
MX (1) MXPA02007018A (es)
NO (1) NO330198B1 (es)
NZ (1) NZ519980A (es)
PE (1) PE20010829A1 (es)
PH (1) PH12000003631B1 (es)
UY (1) UY26545A1 (es)
WO (1) WO2001052667A2 (es)
ZA (1) ZA200206546B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
WO2002078462A1 (en) * 2001-03-30 2002-10-10 Societe Des Produits Nestle S.A. Methods and products for removing tartar from the teeth of a pet
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2007518400A (ja) * 2003-12-04 2007-07-12 バイオフィルムズ ストラテジーズ， インコーポレイテッド バイオフィルムの形成を防止、存在するバイオフィルムを減少、および細菌の個体群を減少させるための方法ならびに組成物
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7935334B2 (en) * 2005-07-07 2011-05-03 Imagilin Technologies, LLC Probiotics as alternative medicines against infectious diseases
US20060008511A1 (en) * 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
AU2006288252B2 (en) * 2005-09-08 2012-01-12 Kabushiki Kaisha Yakult Honsha Cholesterol absorption inhibitor
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
AU2010247469B2 (en) * 2009-05-11 2014-12-18 Société des Produits Nestlé S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
ITMI20091406A1 (it) * 2009-08-03 2011-02-04 Biotecnologie B T S R L Produzione di pellet contenenti sostanze termolabili
EP2449889A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Rice pudding preparations containing probiotic micro-organisms
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
RU2585851C2 (ru) * 2011-12-29 2016-06-10 Хилл'С Пет Ньютришн, Инк. Композиции и способы модификации желудочно-кишечной флоры
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
WO2013180585A1 (en) * 2012-05-29 2013-12-05 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
EP2674162A1 (en) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
ITPD20130133A1 (it) * 2013-05-14 2014-11-15 Sanypet S P A Prodotto per l'alimentazione di cani affetti da disturbi infiammatori dell'intestino
JP6338206B2 (ja) * 2013-12-20 2018-06-06 雪印メグミルク株式会社 抗ヘリコバクター・ハイルマニー剤
JP6329206B2 (ja) * 2016-06-30 2018-05-23 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 消化管フローラを改良する組成物および方法
KR20180078458A (ko) * 2016-12-30 2018-07-10 이경문 동물 개체별 맞춤형 식료품 제공 방법
JP6482045B2 (ja) * 2018-01-30 2019-03-13 雪印メグミルク株式会社 抗ヘリコバクター・ハイルマニー剤
JP2019149977A (ja) * 2018-03-05 2019-09-12 今野 由梨 ペット用サプリメント及びその製造方法
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
EP3812452A4 (en) 2018-09-30 2021-11-03 Inner Mongolia Yili Industrial Group Co., Ltd. BIFIDOBACTERIUM LACTIS BL-99 AND ITS USES
CN111616260A (zh) * 2020-06-04 2020-09-04 广州市中添生物科技有限公司 一种富含犬猫肠道绒毛修复因子的功能性益生菌制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69223615T2 (de) * 1992-07-06 1998-04-09 Nestle Sa Lactobacillus Acidophilus enthaltende Antigastritis-Mittel
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
DE29724815U1 (de) * 1997-01-09 2004-07-22 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
JPH11171783A (ja) * 1997-08-15 1999-06-29 Vetoquinol Sa 所定の動物に関して細胞性免疫と体重増加を生じる濃度でのバクテリアの経口投与
JPH1192390A (ja) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc ストレス状態改善剤
AU4059999A (en) * 1998-06-05 1999-12-30 Wakamoto Pharmaceutical Co., Ltd. Lactic acid bacterium-containing compositions, drugs and foods
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations

Also Published As

Publication number Publication date
NO20023434L (no) 2002-08-20
AU4049401A (en) 2001-07-31
EP1251747B1 (en) 2012-01-25
EP1251747A2 (en) 2002-10-30
PE20010829A1 (es) 2001-09-03
NZ519980A (en) 2004-04-30
CA2396958A1 (en) 2001-07-26
CO5280056A1 (es) 2003-05-30
PH12000003631B1 (en) 2007-11-16
AU784898B2 (en) 2006-07-20
US20030049240A1 (en) 2003-03-13
CA2396958C (en) 2009-11-17
NO330198B1 (no) 2011-03-07
JP5148796B2 (ja) 2013-02-20
JP2011024583A (ja) 2011-02-10
JP5149346B2 (ja) 2013-02-20
ZA200206546B (en) 2004-01-21
ES2378811T3 (es) 2012-04-18
JP2003520038A (ja) 2003-07-02
MXPA02007018A (es) 2002-12-13
WO2001052667A3 (en) 2002-05-02
BR0016973A (pt) 2002-10-15
US7910144B2 (en) 2011-03-22
NO20023434D0 (no) 2002-07-17
UY26545A1 (es) 2001-07-31
ATE542434T1 (de) 2012-02-15
WO2001052667A2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
AR027247A1 (es) Alimento para mascotas destinado al tratamiento de la especie helicobacter en las mascotas.
AR029100A1 (es) Nuevos probioticos para aplicaciones de alimento de mascotas
PT1190068E (pt) Sequencias de acidos nucleicos para proteinas envolvidas na sintese de tocoferol
CO6361864A2 (es) Metodo de uso de una de cepa de bacillus subtilis para mejorar la salud de animales.
ECSP055725A (es) Formulaciones nutricionales que contienen sustancias simbióticas
ATE451845T1 (de) Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
AR003496A1 (es) Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto
AR033574A1 (es) Una cepa bacteriana del grupo de las bacterias lacticas capaces de reducir la tendencia de un individuo a desarrollar reacciones alergicas, las composiciones alimenticias y farmaceuticas que la contienen y las vacunas que la contienen
AR022358A1 (es) Una composicion de epo, un procedimiento para su obtencion, un preparado farmaceutico que la contiene y un procedimiento para aumentar la actividadespecifica de una composicion de epo
Kim et al. Analysis of histone deacetylase inhibitor-induced responses in human periodontal ligament fibroblasts
ATE299854T1 (de) Chinonverbindungen zur behandlung von krankheiten
FR2808191B1 (fr) Extrait de vegetal de l'espece olea europaea comme inhibiteur de no-synthase et utilisations
AR046123A1 (es) Aislamiento de celulas simil-celulas madre, uso de las mismas
BR0112463A (pt) Composições biocidas e métodos e sistemas que empregam as mesmas
Kameri et al. Antibacterial effect of Matricaria chamomilla L. Extract against Enterococcus faecalis
BRPI0416768A (pt) fagos isolados e seu uso como desinfetantes em alimentos ou para sanitização de ambientes de fábricas
ZA202103181B (en) Reduction of pathogenic bacteria using arginine
AR029561A1 (es) (-) CLETODIMA oPTICAMENTE PURA, COMPOSICIONES Y MÉTODOS QUE COMPRENDEN LA MISMA PARA CONTROLAR EL CRECIMIENTO VEGETAL
Mendi Nigella sativa oil could induce osteogenic differentiation of dental pulp mesenchymal stem cells: Clinical nutrition for dentistry
AR034451A1 (es) Microcapsulas para la proteccion frente al mal aliento.
AR042810A1 (es) Tejido higienico apropiado para la limpieza y transferencia de bacterias productoras de acido lactico a la piel o al area urogenital.
AR028672A1 (es) Uso de una cepa de bacterias lacticas exogenas contra enfermedades relacionadas con actinomyces naeslundii
IL175558A0 (en) A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
BR9916726A (pt) HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes
RS52118B (en) PROCEDURE FOR OBTAINING PROTOZOAL CULTURES AND THEIR APPLICATIONS

Legal Events

Date Code Title Description
FG Grant, registration